Daniel A. Arber

University of Illinois Chicago — United States

Medicine · Health Sciences

68h-index33.3kcitations445works5.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(195), Lymphoma Diagnosis and Treatment(119), Myeloproliferative Neoplasms: Diagnosis and Treatment(88), Hematological disorders and diagnostics(55), Chronic Lymphocytic Leukemia Research(53)

Publications445 total

Characterization of chromosome 5 aberrations in <i>TP53</i> mutated myeloid neoplasms with ≥5% blasts: An International <i>TP53</i> Investigators Network (iTiN) study
Cancer·2025Open Access
Chronic myelomonocytic leukemia in the young (aged 50 years and younger): Divergent clinical and molecular characteristics from the elderly
Cancer·2025Open Access
Early assessment of treatment response in AML using FLT PET/cT: a trial of the ECOG-ACRIN Cancer Research Group (EAI141)
Leukemia & lymphoma/Leukemia and lymphoma·2025
MAPS-R: International consensus classification-guided revision of the mayo alliance prognostic system for systemic mastocytosis
Blood·2025Open Access
Prospective study of patient-reported depression, and cognitive and functional impairment, and impact on survival and induction mortality in fit adults age ≥60 years receiving intensive chemotherapy (IC) for Acute Myeloid Leukemia (AML): Prospective geriatric assessment (GA) report from ECOG-ACRIN (EA) E2906 randomized study
Blood·2025
Impact of therapy delays on outcomes in adults with BCR::ABL1 negative b-lineage acute lymphoblastic leukemia (ALL) in the ECOG-ACRIN E1910 trial randomized to conventional chemotherapy +/- blinatumomab
Blood·2025
Bone marrow biopsy characteristics at nadir after intensive induction therapy do not predict outcomes in acute myeloid leukemia (AML): An analysis of ECOG-ACRIN clinical trials
Blood·2025
Genomic determinants of treatment outcome and identification of a new genomic subset of adult acute lymphoblastic leukemia from the ECOG-ACRIN E1910 randomized phase III trial
Blood·2025Open Access
Integrated prognostic model for TP53‑mutated myeloid neoplasms across all myeloid neoplasm subtypes
Blood·2025
Rare composite of Rosai-Dorfman-Destombes disease and nodular lymphocyte-predominant B-cell (Hodgkin) lymphoma
Blood·2025Open Access
Hematolymphoid Neoplasms Involving the Breast: A Single Institution Clinicopathologic Study of 59 Patients
2025Open Access
Acute Leukemias of Ambiguous Lineage With <i>RUNX1</i> Mutations Show Similar Prognosis Compared to Acute Myeloid Leukemia With <i>RUNX1</i> Mutations: A Study From the Bone Marrow Pathology Group
American Journal of Hematology·2025Open Access
Clinical and molecular characterization of TP53-mutant acute lymphoblastic leukemia in adults
Blood Cancer Journal·2025· 4 citedOpen Access
A Clinically Applicable Model Using Blood Counts to Support the Diagnosis of Prefibrotic Myelofibrosis Versus Essential Thrombocythemia
American Journal of Hematology·2025· 1 cited
Acute Myeloid Leukemia
Elsevier eBooks·2025· 3 cited
Systemic Mastocytosis in 910 Patients: Prognostic Contribution of the International Consensus Classification in the Context of the Mayo Alliance Prognostic System
American Journal of Hematology·2025Open Access
Karyotypic clonal fraction predicts adverse outcome in <i>TP53</i> -mutated myeloid neoplasms: an International <i>TP53</i> investigators Network (iTiN) study
Journal of Clinical Pathology·2025· 2 cited
Guide to the diagnosis of lymphoid neoplasms in blood and bone marrow: A Bone Marrow Pathology Group approach
American Journal of Clinical Pathology·2025
The Classification of Hematopoietic Neoplasms: The Why, How, and Who?
Advances in Anatomic Pathology·2025
<i>TP53</i> multihit mutations in 142 patients with MPN or AML: Comparative analysis of survival and risk factors.
Journal of Clinical Oncology·2025
page 1 of 23Next →

Frequent Co-authors

Marilyn L. Slovak(12), Lawrence M. Weiss(8), Robert P. Hasserjian(7), Attilio Orazi(6), Stephen J. Forman(6), Michael J. Borowitz(5), Richard M. Stone(5), Karen Chang(5), Sa A. Wang(4), Adam Bagg(4), Kathryn Foucar(4), Jason Gotlib(4), Martin S. Tallman(4), Olga K. Weinberg(4), Margaret O’Donnell(4), Lisa Ma(4), L. Jeffrey Medeiros(4), Michelle M. Le Beau(3), Mario Cazzola(3), James W. Vardiman(3)